Filtering

Page: () 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 ... 146 ()

1KU Leuven, Department of Clinical and Experimental Medicine, TARGID-IBD, Leuven, Belgium 2University of Cambridge, School of Clinical Medicine, Cambridge, Biomedical Campus, Department of Medicine and Cambridge Institute for Medical Research, Cambridge, United Kingdom 3Hasselt University, Faculty of Medicine and Life Sciences, Hasselt, Belgium 4Jessa Hospital, Hasselt, Belgium 5KU Leuven, Rega Institute for Medical Research, Department of Microbiology and Immunology, Leuven, Belgium 6KU Leuven, Laboratory of Complex Genetics, Department of Human Genetics, Leuven, Belgium 7University Hospitals Leuven, Department of Gastroenterology and Hepatology, Leuven, Belgium 8KU Leuven, Laboratory of Clinical Immunology, Department of Microbiology and Immunology, Leuven, Belgium

P035

TNF-driven pathways are increased at baseline in Crohn's disease patients not responding to infliximab

Year: 2017
Source:

1KU Leuven, Department of Clinical and Experimental Medicine, TARGID-IBD, Leuven, Belgium 2University of Cambridge, School of Clinical Medicine, Cambridge, Biomedical Campus, Department of Medicine and Cambridge Institute for Medical Research, Cambridge, United Kingdom 3Hasselt University, Faculty of Medicine and Life Sciences, Hasselt, Belgium 4Jessa Hospital, Hasselt, Belgium 5KU Leuven, Rega Institute for Medical Research, Department of Microbiology and Immunology, Leuven, Belgium 6KU Leuven, Laboratory of Complex Genetics, Department of Human Genetics, Leuven, Belgium 7University Hospitals Leuven, Department of Gastroenterology and Hepatology, Leuven, Belgium 8KU Leuven, Laboratory of Clinical Immunology, Department of Microbiology and Immunology, Leuven, Belgium

Authors:

Verstockt B.*1,2, Arijs I.1,3,4, de Bruyn M.1,5, Verstockt S.6, Van Assche G.1,7, Breynaert C.8, Vermeire S.1,7, Ferrante M.1,7

P036

Colon targeted delivery of tofacitinib inhibits oxazolone-induced colitis in mice, despite low systemic exposure

Year: 2016
Authors:

F. Shen*, P. Brassil, S. Hegde, D. Beattie

Theravance Biopharma, South San Francisco, California, United States

1University of Manchester, MCCIR, Manchester, United Kingdom 2University of Manchester, Wellcome Trust Centre for Cell-Matrix Research, Manchester, United Kingdom 3University of Manchester, Manchester Immunology Group, Manchester, United Kingdom 4Central Manchester NHS Hospitals Foundation Trust, Department of Gastroenterology, Manchester, United Kingdom

P036

Human peripheral blood monocytes and intestinal macrophage populations activate transforming growth factor beta via expression of the integrin alpha v beta 8

Year: 2017
Source:

1University of Manchester, MCCIR, Manchester, United Kingdom 2University of Manchester, Wellcome Trust Centre for Cell-Matrix Research, Manchester, United Kingdom 3University of Manchester, Manchester Immunology Group, Manchester, United Kingdom 4Central Manchester NHS Hospitals Foundation Trust, Department of Gastroenterology, Manchester, United Kingdom

Authors:

Shuttleworth E.*1,2,3, Kelly A.1,2,3, Fenton T.1,2,3, Smedley C.1,2,3, Levison S.4, Travis M.1,2,3

1University of Edinburgh, MRC Centre for Inflammation Research, Edinburgh, United Kingdom 2University of North Carolina, Chapel Hill, United States 3University of Chiba, Chiba, Japan

P037

MDR1-deficiency unmasks mitochondrial dysfunction as a pathogenic mechanism in IBD

Year: 2017
Source:

1University of Edinburgh, MRC Centre for Inflammation Research, Edinburgh, United Kingdom 2University of North Carolina, Chapel Hill, United States 3University of Chiba, Chiba, Japan

Authors:

Ho G.-T.*1, Aird R.1, Boyapati R.1, Liu B.2, Kennedy N.1, Shimizu T.3, Sartor B.2, Satsangi J.1

P037

Remodelling events preceding clinical onset of intestinal inflammation reveal the predictive power of the extracellular matrix

Year: 2016
Authors:

E. Shimshoni*1, R. Afik1, L. Puricelli2, A. Shenoy3, T. Geiger3, A. Podestà2, I. Sagi1

1Weizmann Institute of Science, Biological Regulation, Rehovot, Israel, 2University of Milan, Physics, Milan, Italy, 3Tel Aviv University, Human Genetics, Tel Aviv, Israel

P038

Revised roles of matrix metalloproteinase/MMP-9 in inflammatory bowel diseases: from target to biomarker

Year: 2016
Authors:

M. de Bruyn*1, 2, C. Breynaert3, I. Arijs2, G. De Hertogh4, K. Geboes4, G. Thijs1, J. Hu5, J. Van Damme1, B. Arnold6, M. Ferrante7, S. Vermeire7, G. Van Assche7, J. Ceuppens3, G. Opdenakker1

1Rega Institute for Medical Research, KU Leuven, Department of Microbiology and Immunology, Leuven, Belgium, 2Translational Research Centre for Gastrointestinal Disorders (TARGID), KU Leuven, Department of Clinical and Experimental Medicine, Leuven, Belgium, 3Laboratory of Clinical Immunology, KU Leuven, Department of Microbiology and Immunology, Leuven, Belgium, 4Translational Cell and Tissue Research, KU Leuven, Department of Imaging and Pathology, Leuven, Belgium, 5Key Laboratory of Modern Chinese Medicines, China Pharmaceutical University, Ministry of Education, Nanjing, China, 6German Cancer Research Centre (DKFZ), Department of Molecular Immunology, Heidelberg, Germany, 7University Hospitals Leuven, KU Leuven, Department of Gastroenterology, Leuven, Belgium

1University of Campinas, Coloproctology Unit, Surgery Department, Campinas, Brazil 2University of Campinas, Campinas, Brazil 3University of Campinas, Laboratory of Cell Signaling, Internal Medicine Department, Campinas, Brazil

P038

Tissue differences in the pro-inflammatory activation of ER stress of patients with Crohn's disease

Year: 2017
Source:

1University of Campinas, Coloproctology Unit, Surgery Department, Campinas, Brazil 2University of Campinas, Campinas, Brazil 3University of Campinas, Laboratory of Cell Signaling, Internal Medicine Department, Campinas, Brazil

Authors:

Coope A.*1, Botezelli J.D.2, Bitencourt Pascoal L.1, Ramos Silva F.1, Ayrizono M.L.S.1, Milanski M.2, Velloso L.A.3, Leal R.F.1

P039

Expression of the liver homing receptor CXCR3+ on colonic CD8+ T lymphocytes in patients with primary sclerosing cholangitis provides a possible link between colonic and biliary duct inflammation.

Year: 2016
Authors:

M. Lampinen*1, A. Fredricsson1, J. Vessby1, A. Wanders2, F. Rorsman1, M. Carlson1

1Uppsala University, Medical Sciences, Uppsala, Sweden, 2Umeå University, Medical Biosciences, Umeå, Sweden

University Hospital of Heidelberg, Internal Medicine IV, Dept. of Gastroenterology, Heidelberg, Germany

P039

Suppression of phospholipase A2 of intestinal microbiota by the phospholipid-bile acid conjugate ursodeoxycholate-lysophoshatidylethanolamide ameliorates mucosal inflammation in a genetic mouse model of ulcerative colitis

Year: 2017
Source:

University Hospital of Heidelberg, Internal Medicine IV, Dept. of Gastroenterology, Heidelberg, Germany

Authors:

Stremmel W., Staffer S., Stuhrmann N., Gauss A., Burger N., Hornuss D.

Kyoto University Graduate School of Medicine, Gastroenterology and Hepatology, Kyoto, Japan

P040

Intestinal EP4 receptor is required for homeostasis of the colon in mice

Year: 2017
Source:

Kyoto University Graduate School of Medicine, Gastroenterology and Hepatology, Kyoto, Japan

Authors:

Matsumoto Y., Fukuda A., Seno H.

P040

Sonic hedgehog inhibitor prevented colitis-associated cancer via concerted mechanisms of IL-6/gp130 inhibition, 15-prostaglandin dehydrogenase induction, Bcl-2 abrogation, and tumour sphere inhibition

Year: 2016
Authors:

K. B. Hahm*1, N. Kangwan1, Y. J. Kim2

1CHA University, Gastroenterology, Seongnam, South Korea, 2Gachon University, Gastroenterology, Incheon, South Korea

P041

Automated image analysis as a diagnostic tool in discriminating between subgroups of microscopic colitis

Year: 2016
Authors:

A.-M. Kanstrup-Fiehn1, M. Kristensson2, U. H. Engel3, L. K. Munck4, 5, 
S. Holck3, P. J. H. Engel*1, 5

1Roskilde Hospital, Department of Pathology, Roskilde, Denmark, 2Visiopharm, Hoersholm, Denmark, 3Copenhagen University Hospital, Department of Pathology, Hvidovre, Denmark, 4Koege Sygehus, Department of Gastroenterology, Koege, Denmark, 5University of Copenhagen, Faculty of Health and Medical Sciences, Copenhagen, Denmark

1University Hospital RWTH Aachen, Department of Internal Medicine III, Aachen, Germany 2University Hospital RWTH Aachen, Department of Microbiology, Aachen, Germany 3Howard Hughes Medical Institute and University of Massachusetts Medical School, Worcester, United States 4University Hospital RWTH Aachen, Interdisciplinary Center for Clinical Research (IZKF), Aachen, Germany 5Klinikum Braunschweig, Institute of Pathology, Braunschweig, Germany 6Gemeinschaftsklinikum Mittelrhein - Kemperhof, Department of Gastroenterology, Kobelnz, Germany 7geneXplain GmbH, Wolfenbüttel, Germany

P041

C-jun n-terminal kinase 2 promotes enterocyte survival and goblet cell differentiation in the inflamed intestine

Year: 2017
Source:

1University Hospital RWTH Aachen, Department of Internal Medicine III, Aachen, Germany 2University Hospital RWTH Aachen, Department of Microbiology, Aachen, Germany 3Howard Hughes Medical Institute and University of Massachusetts Medical School, Worcester, United States 4University Hospital RWTH Aachen, Interdisciplinary Center for Clinical Research (IZKF), Aachen, Germany 5Klinikum Braunschweig, Institute of Pathology, Braunschweig, Germany 6Gemeinschaftsklinikum Mittelrhein - Kemperhof, Department of Gastroenterology, Kobelnz, Germany 7geneXplain GmbH, Wolfenbüttel, Germany

Authors:

Mandić A.D.1, Bennek E.1, Verdier J.1, Zhang K.2, Roubrocks S.1, Davis R.J.3, Denecke B.4, Gassler N.5, Streetz K.6, Kel A.7, Hornef M.2, Cubero F.J.1, Trautwein C.1, Sellge G.*1

P042

Circulating IL9 in inflammatory bowel disease: possible marker of mucosal non-healing

Year: 2016
Authors:

K. Neubauer*1, M. Krzystek-Korpacka2, M. Matusiewicz2, M. Zawadzki3, I. Bednarz-Misa2, S. Górska4, W. Witkiewicz5, A. Gamian6, 7

1Wroclaw Medical University, Gastroenterology and Hepatology, Wroclaw, Poland, 2Wroclaw Medical University, Medical Biochemistry, Wroclaw, Poland, 3Regional Specialist Hospital, Vascular Surgery, Wroclaw, Poland, 4LudwikHirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Laboratory of Medical Microbiology, Wroclaw, Poland, 5Research and Development Centre at Regional Specialist Hospital, Wroclaw, Poland, 6Medical Wroclaw University, Medical Biochemistry, Wroclaw, Poland, 7LudwikHirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wroclaw, Poland

1Instituto Nacional de Ciencias Médicas y Nutriciόn Salvador Zubiran, Inflammatory Bowel Disease Clinic. Department of Gastroenterology, Mexico City, Mexico 2Instituto Nacional de Ciencias Médicas y Nutriciόn, Department of Immunology and Rheumatology, Mexico, Mexico

P042

Expression of IL-38 and their antagonists in patients with inflammatory bowel disease

Year: 2017
Source:

1Instituto Nacional de Ciencias Médicas y Nutriciόn Salvador Zubiran, Inflammatory Bowel Disease Clinic. Department of Gastroenterology, Mexico City, Mexico 2Instituto Nacional de Ciencias Médicas y Nutriciόn, Department of Immunology and Rheumatology, Mexico, Mexico

Authors:

Fonseca Camarillo G.*1, Furuzawa Carballeda J.2, Iturriaga Goyon E.1, Yamamoto Furusho J.K.1

P043

Inhibition of miR-142-5P ameliorates disease in mouse models of experimental colitis

Year: 2016
Authors:

N. Duijvis*1, C. Kunne1, M. Slaman1, F. van Dooren1, E. Vogels1, S. Meijer2, K. Fluiter3, P. Moerland3, A. te Velde1

1Academic Medical Centre (AMC), Tytgat Institute for Liver and Intestinal Research, Amsterdam, Netherlands, 2Academic Medical Centre (AMC), Department of Pathology, Amsterdam, Netherlands, 3Academic Medical Centre (AMC), Department of Clinical Epidemiology, Amsterdam, Netherlands

1University College London, Molecular Medicine, London, United Kingdom 2University College London Hospital, Gastroenterology, London, United Kingdom 3University of Manchester, Division of Pharmacy and Optometry, Manchester, United Kingdom 4University College London, Clinical Pharmacology, London, United Kingdom

P043

Ulcerative colitis is characterised by an exaggerated onset of acute inflammation with delayed resolution

Year: 2017
Source:

1University College London, Molecular Medicine, London, United Kingdom 2University College London Hospital, Gastroenterology, London, United Kingdom 3University of Manchester, Division of Pharmacy and Optometry, Manchester, United Kingdom 4University College London, Clinical Pharmacology, London, United Kingdom

Authors:

Marks D.*1,2, Wysoczanski R.1, Kendall A.3, Motwani M.4, Vega R.2, Rahman F.2, McCartney S.2, Bloom S.2, Nicolaou A.3, Gilroy D.4, Segal A.1

P044

Roles of IL-33 on murine colitis and M2 macrophage differentiation in inflammatory bowel diseases

Year: 2016
Authors:

D. H. Seo*1, 2, M. S. Kawk1, X. Che1, 2, H. W. Ma1, 2, J. H. Kim1, 2, D. H. Kim1, T. I. Kim1, W. H. Kim1, S. W. Kim1, 2, 3, J. H. Cheon1, 2, 3

1Yonsei University, Department of Internal Medicine and Institute of Gastroenterology, College of Medicine, Seoul, South Korea, 2Yonsei University, Brain Korea 21 PLUS Project for Medical Science, College of Medicine, Seoul, South Korea, 3Yonsei University, Severance Biomedical Science Institute, College of Medicine, Seoul, South Korea

1Yonsei University Wonju College of Medicine, Internal medicine, Wonju, South Korea 2Yonsei University Wonju College of Medicine, Cell Therapy and Tissue Engineering Center, Wonju, South Korea 3Yonsei University Wonju College of Medicine, Pathology, Wonju, South Korea

P044

Therapeutic effects of mesenchymal stem cells induced regulatory dendritic cells on chronic colitis model in mice

Year: 2017
Source:

1Yonsei University Wonju College of Medicine, Internal medicine, Wonju, South Korea 2Yonsei University Wonju College of Medicine, Cell Therapy and Tissue Engineering Center, Wonju, South Korea 3Yonsei University Wonju College of Medicine, Pathology, Wonju, South Korea

Authors:

Kim H.-S.*1, Jo H.1, Eom Y.W.2, Cho M.Y.3

1University College London, Molecular Medicine, London, United Kingdom 2University of Manchester, Division of Pharmacy and Optometry, Manchester, United Kingdom 3University College London, Clinical Pharmacology, London, United Kingdom 4University College London Hospital, Gastroenterology, London, United Kingdom

P045

5-Aminosalicylates promote inflammation resolution in ulcerative colitis through generation of anti-inflammatory hydroxy fatty acids

Year: 2017
Source:

1University College London, Molecular Medicine, London, United Kingdom 2University of Manchester, Division of Pharmacy and Optometry, Manchester, United Kingdom 3University College London, Clinical Pharmacology, London, United Kingdom 4University College London Hospital, Gastroenterology, London, United Kingdom

Authors:

Wysoczanski R.*1, Kendall A.2, Motwani M.3, Vega R.4, Rahman F.4, McCartney S.4, Bloom S.4, Nicolaou A.2, Gilroy D.3, Segal A.1, Marks D.1,4

Page: () 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 ... 146 ()